Navigation Links
Alpine Biomed Corporation to Integrate Bravo pH Monitoring With GastroTrac Software to Enhance Gastrodiagnostic Testing Capabilities
Date:5/15/2009

Company Signs Agreement with Given Imaging Ltd. to Offer Customers Integrated Testing Solution

FOUNTAIN VALLEY, Calif., May 15 /PRNewswire/ -- Alpine Biomed Corporation, a global leader in specialty diagnostic devices, announced today that it has signed an agreement with Given Imaging Ltd. to enhance its gastrodiagnostic testing capabilities. The company's GastroTrac(R) gastroenterology software suite will interface with Given Imaging's Bravo(R) pH Monitoring System to provide doctors with a single system for their gastrointestinal testing needs.

Alpine Biomed will incorporate the Bravo pH software into a fully integrated version of GastroTrac with a comprehensive range of tests including catheter-based pH monitoring, upper and lower GI motility testing, electrogastrography and biofeedback. To simplify patient records, the Bravo pH software will share the GastroTrac database with the catheter-based pH monitoring studies. Alpine Biomed's VersaFlex(R) pH catheters and the Bravo pH capsule are the only pH devices validated for use on the integrated GastroTrac system.

"We are pleased to offer our customers a single solution for their gastrodiagnostic testing needs. This agreement will significantly benefit both our current and new customers. We look forward to working with our customers to implement an integrated solution that will better serve their practices," said Alpine Biomed President and CEO John Arnott.

Alpine Biomed is exhibiting at the Society for Gastroenterology Nurses and Associates Annual Course in St. Louis, May 17-19 (booth 737) and at the Digestive Disease Week meeting in Chicago May 31- June 3 (booth 1801).

About Alpine Biomed

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux disease (GERD), commonly referred to as acid reflux disease, as well as for neurological conditions such as sleep disorders. Founded in 1994, Alpine Biomed is headquartered in Fountain Valley, California with manufacturing facilities in Canada, Denmark and Vietnam. For more information about Alpine Biomed, visit www.alpinebiomed.com or contact William Brown, 714-839-8426.

About Given Imaging Ltd.

Since 2001, Given Imaging has advanced gastrointestinal diagnosis by developing innovative, patient-friendly tools based on its PillCam(R) Platform. PillCam capsule endoscopy provides physicians with natural images of the small intestine via PillCam SB, the esophagus through PillCam ESO and the colon with PillCam COLON [not cleared for use in the USA]. The PillCam capsules are miniature video cameras that patients ingest. Given Imaging's other capsule products include Agile(TM) patency capsule, to verify intestinal patency, and Bravo(R), the only wireless, catheter-free, 48-hour pH test commercially available for pH testing to assess gastroesophageal reflux disease (GERD). Given Imaging's products use cutting-edge wireless technology and advanced software to enable gastroenterologists to better diagnose and more accurately treat patients. All Given Imaging products allow patients to maintain normal activities. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel, with operating subsidiaries in the United States, Germany, France, Japan, Australia and Singapore. For more information, please visit http://www.givenimaging.com.


'/>"/>
SOURCE Alpine Biomed Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
2. BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock
3. BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock
4. Response Biomedical Announces Proposed Unit Offering
5. BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
6. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
7. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
8. Four legendary LA BioMed physician-researchers honored
9. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
10. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
11. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Bill Howe Plumbing, Heating & Air in San Diego announces ... Healthy is Your Heart Drawing Contest The drawing contest asks children to draw ... Heating & Air receives over 600 entries. The culmination of the joint effort will ...
(Date:1/19/2017)... Falls Church, VA (PRWEB) , ... January 19, 2017 , ... ... Know to Thrive in 2017, **An FDAnews Webinar**, Jan. 26, 2016 — 1:30 p.m. ... to know about the 21st Century Cures Act in order to thrive this year? ...
(Date:1/19/2017)... ... January 19, 2017 , ... "ProParagraph Basics is ... the editing process for all media productions," said Christina Austin - CEO of ... simplistically styled self-animating paragraphs designed for multi-lined text purposes. Choose from presets ...
(Date:1/19/2017)... ... January 19, 2017 , ... Each ... Surgery Symposium, a conference where hundreds of surgeons from over fifteen different countries ... topics from cosmetic breast augmentation to breast reconstruction for breast cancer ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for building ... know that popular cosmetic fillers can enhance earlobes and rejuvenate an ... of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “People ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
Breaking Medicine Technology: